IMMU-53. CO-ADMINISTRATION OF DEXAMETHASONE WITH CHECKPOINT BLOCKADE THERAPY INCREASES SURVIVAL IN BRAIN TUMOR MODEL

BACKGROUND: The use of corticosteroids for therapeutic benefit must be weighed against risks of adverse consequences associated with these drugs. Brain tumor patients are routinely prescribed dexamethasone to reduce tumor-associated edema. Checkpoint blockade, a type of immune therapy, is currently...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Neuro Oncol
Main Authors: Hutchinson, Marsha-Kay, Giles, Amber, Sonnemann, Heather, Reid, Caitlin, Park, Deric M, Gilbert, Mark R
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2017
Teme:
Abstracts
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5692480/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.511
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki